Keywords
Bipolar Affective Disorder
Psychiatry
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To investigate the importance of adherence to pharmacological treatment combined with cognitive behavioral psychotherapy in Bipolar Affective Disorder. Bibliographic review: Combined treatment between psychotherapy based on Cognitive Behavioral Therapy and psychopharmacological management is essential in promoting a reduction in mood swings and symptoms, both in depressive and high mood phases. In addition, factors such as adequate psychoeducation, a support network and a consistent pharmacological treatment plan are factors that corroborate treatment adherence in Bipolar Affective Disorder, with stabilizers and antipsychotics being two important lines of pharmacology used. Furthermore, non-adherence to treatment can lead to greater damage during mood swings, neurocognitive impairment and difficulties in regulating mood, which directly interferes with patients' quality of life. Final considerations: The combined treatment of cognitive behavioral psychotherapy and psychopharmacology is indispensable for promoting greater well-being in the lives of patients with Bipolar Affective Disorder. Difficulties or lack of adherence to treatment can lead to damage to quality of life, neurocognitive impairment and difficulties in maintaining the patient's euthymia.
References
CHIANG KJ, et al. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials. PLoS One, 2017; 12(5): e0176849.
CORDIOLI AV, KNAPP P. A terapia cognitivo-comportamental no tratamento dos transtornos mentais. Revista Brasileira de Psiquiatria, 2008; 30(supl. 2): S51–S53.
COSTA RT, et al. The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: A randomized controlled study. Revista Brasileira de Psiquiatria, 2011; 33(2): 144–149.
CRADDOCK N, SKLAR P. Genetics of bipolar disorder. The Lancet, 2013; 381(9878): 1654–1662.
FREY BN, et al. Anormalidades neuropatológicas e neuroquímicas no transtorno afetivo bipolar. Revista Brasileira de Psiquiatria, 2004; 26(3): 180–188.
FREY BN, et al. Marcadores periféricos e a fisiopatologia do transtorno bipolar. Revista de Psiquiatria Clínica, 2007; 34(2): 41–47.
HOVATTA I. Bipolar disorder: Challenges in diagnosis and treatment. Department of Psychiatry, University of Helsinki, 2024.
KAPCZINSKI F, FREY BN, ZANNATTO V. As bases neurobiológicas do transtorno bipolar. Revista de Psiquiatria Clínica, 2004; 31(3): 125–132.
KAUER-SANT'ANNA M, et al. Atualização sobre o tratamento do transtorno bipolar: foco na lamotrigina. Revista de Psiquiatria do Rio Grande do Sul, 2004; 26(3): 278–287.
MARTINEZ-ARAN A, et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. The Journal of Clinical Psychiatry, 2009; 70(7): 1017–1023.
MAZZAIA MC, SOUZA MA. Adesão ao tratamento no transtorno afetivo bipolar – percepção do usuário e do profissional de saúde. Texto & Contexto Enfermagem, 2014; 23(3): 753–761.
MEIRA M. Tratamentos farmacológicos e terapias psicossociais no Transtorno Bipolar. Brazilian Journal of Health Review, 2023; 6(6): 27556–27570.
MENDES CV, et al. A influência dos aspectos subjetivos na adesão ao tratamento do transtorno bipolar: uma revisão sistemática. Jornal Brasileiro de Psiquiatria, 2020; 69(1): 1–9.
MIASSO AI, et al. Transtorno afetivo bipolar: adesão ao medicamento e satisfação com o tratamento e orientações da equipe de saúde de um Núcleo de Saúde Mental. Revista Latino-Americana de Enfermagem, 2009; 17(4): 548–554.
MIHRETIE EA, et al. Association between history of bipolar affective disorder and risk of dementia among older adults: a systematic review and meta-analysis. Scientific Reports, 2024; 14: 221.
NIERENBERG AA, et al. Diagnosis and treatment of bipolar disorder: A review. JAMA, 2023; 330(14): 1370–1380.
NUNES MRT, et al. Transtorno afetivo bipolar: fatores psicossociais associados à adesão ao tratamento. Archives of Clinical Psychiatry (São Paulo), 2022; 49(2): 42–47.
PAN J, et al. A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes. Frontiers in Psychiatry, 2023; 14: 1057780.
SADY PC, PASSOS JC. Intervenções psicossociais no transtorno bipolar: psicoeducação e terapia cognitivo-comportamental como fatores de adesão ao tratamento. Revista Fisioterapia e Terapias, 2023; 5(1): 12–18.
SAJATOVIC M, DAVIES M, HROUDA DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatric Services, 2004; 55(3): 264–269.
SANTIN A, CERESÉR K, ROSA A. Adesão ao tratamento no transtorno bipolar. Revista de Psiquiatria Clínica, 2011; 38(5): 221–228.
SANTIN A, et al. Tratamento farmacológico do transtorno bipolar: uma revisão sistemática e crítica dos aspectos metodológicos dos estudos clínicos modernos. Revista Brasileira de Psiquiatria, 2019; 41(4): 333–343.
TAMENE FB, et al. Medication non-adherence and its predictors among patients with bipolar disorder in Northwest Ethiopia. Scientific Reports, 2025; 15(1192): 1–9.
VIEIRA RM, SANTIN A. O papel da equipe multidisciplinar no manejo do paciente bipolar. Revista Brasileira de Psiquiatria, 2004; 26(supl. III): 51–53.
YOUNG LT, MANJI HK. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Journal of Affective Disorders, 2004; 78(1): 1–10.